Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature

Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the Literature

Marta Peri,1 Nicola Fazio2 1Medical Oncology, Department of Surgical, Oncological and Stomatological Sciences, University of Palermo, Palermo, Italy; 2Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, IRCCS, Milan, ItalyCorrespondence: Nico...

Full description

Bibliographic Details
Main Authors: Peri M, Fazio N
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:Lung Cancer : Targets and Therapy
Subjects:
lung net
typical carcinoid
atypical carcinoid
everolimus
mammalian target of rapamycin (mtor) inhibitor
targeted agents
Online Access:https://www.dovepress.com/clinical-evaluation-of-everolimus-in-the-treatment-of-neuroendocrine-t-peer-reviewed-article-LCTT

Internet

https://www.dovepress.com/clinical-evaluation-of-everolimus-in-the-treatment-of-neuroendocrine-t-peer-reviewed-article-LCTT

Similar Items